home / stock / mor / mor news

MOR News and Press, MorphoSys AG From 12/11/23

Stock Information
Company Name: MorphoSys AG
Stock Symbol: MOR
Market: NASDAQ
Website: morphosys.com
Menu
MOR MOR Quote MOR Short MOR News MOR Articles MOR Message Board
Get MOR Alerts

News, Short Squeeze, Breakout and More Instantly...
MOR - MorphoSys climbs after late-stage data for blood cancer therapy

2023-12-11 13:57:54 ET More on MorphoSys MorphoSys: A Buying Opportunity Following Mixed Phase 3 Results In Myelofibrosis MorphoSys: Buying Constellation Was A Desperate Measure MorphoSys: Still Positive Moving Into Pelabresib Data (Maintaining Buy Rating) Mo...
MOR - GTHX, MRKR and CLIR among mid-day movers

2023-12-11 12:51:49 ET Gainers: Jet.AI ( JTAI ) +70% . Boqii Holding Limited ( BQ ) +34% . Marker Therapeutics ( MRKR ) +34% . Morphosys AG ( MOR ) +25% . G1 Therapeutics ( GTHX ) +24% . Innoviz Technologies Ltd ( INVZ ) ...

MOR - Veru, Kodiak Sciences among healthcare movers

2023-12-11 10:00:03 ET More on Health Care Select Sector SPDR Ideal Pairs Trade Into 2024: Health Vs. Hype: Capitalizing On A Therapeutic Turn And A Tech Tumble Health Care Select Sector Fund ETF: Riding The Healthcare Boom For further details see: Veru, Kodiak S...

MOR - MorphoSys' Pelabresib Improves All Four Hallmarks of Myelofibrosis in Phase 3 MANIFEST-2 Study

Pelabresib and ruxolitinib combination significantly reduced spleen size, with an SVR35 response rate nearly double that of placebo plus ruxolitinib Showed a strong positive trend in reducing symptom burden and a twofold increase in patients achieving both SVR35 and TSS50 versus placebo p...
MOR - Geron: Lancet Publication Derisks Imetelstat Opportunity Narrowly Makes Bull Case

2023-12-04 13:50:57 ET Summary Geron Corporation has submitted its New Drug Application (NDA) to the FDA for its lead candidate, imetelstat, for the treatment of transfusion-dependent anemia in adult patients with myelodysplastic syndromes. The FDA has accepted Geron's NDA and wil...

MOR - SEEL, AMPE and MOR among pre-market losers

2023-12-01 08:25:56 ET Losers: Smart for Life ( SMFL ) -38% announces exercise of warrants for $1.5 Million gross proceeds . Ampio Pharmaceuticals ( AMPE ) -34% . Incannex Healthcare ( IXHL ) -34% . Vivos Therapeutics ( VVOS ) -14% . ...

MOR - ALT, CARM and WOOF are among after hour movers

2023-11-30 17:13:46 ET Gainers: Altimmune ( ALT ) +64% . Domo ( DOMO ) +11% . Ulta Beauty ( ULTA ) +9% . Carisma Therapeutics ( CARM ) +5% . Brookfield Property Partners ( BPYPM ) +4% . Losers: Super Micro Computer ( SM...
MOR - 24/7 Market News Lunch Break 30 Nov 2023

2023-11-30 12:24:56 ET DENVER, Colo., Nov. 30, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual midday volume; VinFast Auto Ltd (NASDAQ: VFS), Minim Inc (NASDAQ: MINM), Smart for Life Inc (NASDAQ: SMFL), Ampio Pha...

MOR - MorphoSys: A Buying Opportunity Following Mixed Phase 3 Results In Myelofibrosis

2023-11-27 14:00:44 ET Summary MorphoSys announced positive topline results from its phase 3 trial of pelabresib in frontline myelofibrosis, nearly doubling spleen volume reduction (the primary endpoint) compared to placebo. However, key secondary endpoints assessing symptomatic i...

MOR - Alterity Therapeutics, Edesa Biotech among healthcare movers

2023-11-22 10:00:14 ET More on Health Care Select Sector SPDR Ideal Pairs Trade Into 2024: Health Vs. Hype: Capitalizing On A Therapeutic Turn And A Tech Tumble Health Care Select Sector Fund ETF: Riding The Healthcare Boom Stocks to watch in the Health Care sector a...
Previous 10 Next 10